Evoke Wealth’s Herbalife HLF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.01M Sell
204,480
-49
-0% -$800 0.05% 133
2025
Q4
$2.64M Buy
+204,529
New +$2.17M 0.05% 144
2022
Q4
Sell
-4,106
Closed -$82K 706
2022
Q3
$82K Hold
4,106
﹤0.01% 442
2022
Q2
$84K Hold
4,106
﹤0.01% 435
2022
Q1
$125K Sell
4,106
-7,886
-66% -$308K ﹤0.01% 404
2021
Q4
$491K Buy
11,992
+4,106
+52% +$171K 0.02% 244
2021
Q3
$334K Hold
7,886
0.01% 271
2021
Q2
$416K Hold
7,886
0.02% 258
2021
Q1
$350K Hold
7,886
0.02% 247
2020
Q4
$379K Sell
7,886
-80,498
-91% -$3.88M 0.03% 176
2020
Q3
$4.12M Buy
88,384
+80,498
+1,021% +$3.95M 0.33% 29
2020
Q2
$355K Hold
7,886
0.03% 138
2020
Q1
$230K Sell
7,886
-40
-0.5% -$1.49K 0.03% 165
2019
Q4
$378K Hold
7,926
0.05% 146
2019
Q3
$300K Buy
+7,926
New +$309K 0.04% 199

Other funds holding HLF

Evoke Wealth's HLF Position: Q1 2026 in Review

Evoke Wealth reduced its Herbalife (HLF) stake by 0.02% in Q1 2026, selling an estimated $800 and leaving 204,480 shares worth $3.01M. The position accounts for 0.05% of the portfolio, ranked #133.

Evoke Wealth first reported a position in HLF in Q3 2019 and has held it in 15 quarters since. The position peaked at $4.12M in Q3 2020. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.

  • Evoke Wealth held 204,480 shares of Herbalife worth $3.01M as of Q1 2026.
  • Evoke Wealth sold 49 Herbalife shares in Q1 2026, an estimated $800.
  • Herbalife made up 0.05% of Evoke Wealth's portfolio in Q1 2026, its #133 holding.
  • Evoke Wealth first reported a position in Herbalife in Q3 2019 and has held it in 15 quarters since.
  • Evoke Wealth's Herbalife position peaked at $4.12M in Q3 2020.
  • 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.

Based on Evoke Wealth's 13F filing for Q1 2026, filed 15 May 2026.